VANCOUVER, British Columbia and MENLO PARK, Calif., June 1, 2015 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (“DelMar” and the “Company”), a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug…


Source: PrNewwire

Related Posts Plugin for WordPress, Blogger...